Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Peramivir

A neuraminidase inhibitor, blocking the enzyme the influenza virus uses to break free from infected cells; it is given as a single intravenous infusion. It was approved in Japan in 2010 and in the United States in 2014. This family brings together the active ingredient, nitrosamines and other impurities.

Did you know?Even before its full approval, in October 2009 it was authorised for emergency use in the United States for hospitalised patients during the H1N1 influenza pandemic.

PeramivirGo to the active ingredient →
PeramivirActive ingredientPeramivirCat. No. P-P057-001CAS 330600-85-6

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.